CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
It is an observational study.other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04341324
NCT04341324N/ACompleted

Prospective Study of the Effect of Androgen Deprivation Therapy (ADT) in Male Patients Suffered Prostate Cancer in Chinese Population

Chinese University of Hong Kong·observational·Posted Apr 10, 2020·Updated Apr 10, 2020

In Brief

An observational study evaluating It is an observational study. for Prostate Cancer. Completed, enrolled 60 participants.

Detailed Summary

Many prostate cancer patients required the use of androgen deprivation therapy (ADT) for the control of disease. In this study, the investigators aim at assessing the different in various parameters between PCa patients received ADT and those without ADT. 60 patients diagnosed with PCa and planned for hormonal therapy will be recruited for study (active arm) and 30 PCa patients that do not planned to receive hormonal therapy (based on the clinical assessment by the investigators) will be recruited as control arm. After written consent obtained from study subject, a series of investigation will be arranged to assess the following aspect of the subjects before the commenced of ADT: * General condition - symptoms, general health, * Body composition - BMI and body composition * Mental state assessment by Mini-Mental State Examination (MMSE) * Blood for fasting lipid, sugar, hsCRP and other hormones (about 15cc) * Cardiovascular status - BP, Ankle-brachial index (ABI), Arterial stiffness, ECG, * Bone status - bone mineral density by dual-energy X-ray absorptiometry (DEXA) scan The assessment of general condition, body composition, blood parameter and cardiovascular status will be performed every 26weeks +/- 1 weeks for two years. Bone density measurement will be performed every 52 weeks +/- 2 weeks. Appropriate medical referral will be made if subject was found to have abnormal metabolic or cardiovascular parameters.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 10, 2020
Enrollment StartJul 14, 2011
Primary CompletionDec 4, 2019
TodayJul 1, 2026
Enrollment to primary: 8.4 yearsPosted 6.2 years ago

Interventions

It is an observational study.other